TB-500: Handling, Storage, and Reconstitution Guide

This guide covers laboratory handling, storage, and reconstitution of TB-500, the thymosin beta-4 actin-binding fragment, as a lyophilized research peptide. Every step below is framed as laboratory best practice for in-vitro and animal-model preparation, not as human-use instruction.

TB-500 Handling and Storage Fundamentals

TB-500 ships as a solid, white lyophilized powder in a sealed glass vial. Store the lyophilized material at or below 25 degrees Celsius, sealed, and protected from heat, light, and moisture. For extended storage, keep it lyophilized and refrigerated or frozen. Minimizing exposure to humidity and temperature swings preserves integrity across a study.

Puritide supplies TB-500 in 5 mg and 10 mg vials, so working-stock concentration follows from the diluent volume chosen for the labeled mass.

As a short acetylated heptapeptide, TB-500 is convenient to handle and generally dissolves readily. The handling emphasis is on the fundamentals that keep a lyophilized peptide reliable: moisture and heat protection, gentle reconstitution, single-use aliquoting, and stable cold-chain storage across the study period. Because TB-500 is supplied in more than one vial size, recording which size a given stock came from, alongside its concentration, keeps preparations from being confused when several are in use at once.

Confirm Identity Before Use

Verify the material against its documentation: molecular formula C38H68N10O14, molecular weight approximately 889.0 g/mol, and CAS number 885340-08-9, with synonyms including Ac-LKKTETQ and thymosin beta-4 fragment (17-23). Matching these to the certificate of analysis is the first traceability checkpoint and anchors the actin and migration assays in the TB-500 mechanism of action.

Reconstitution for In-Vitro Preparation

Reconstitute lyophilized TB-500 with bacteriostatic water or another solvent appropriate to the assay. Add the diluent slowly down the inner wall of the vial rather than onto the powder, and allow the peptide to dissolve gently. Swirl; do not vortex aggressively or shake, which can shear the peptide.

• Introduce diluent against the vial wall, not onto the pellet.
• Allow gentle, complete dissolution.
• Inspect the solution before use.
• Compute concentration from labeled mass and diluent volume.

Aliquoting to Limit Freeze-Thaw

Divide reconstituted TB-500 into single-use aliquots so each experiment draws from a vial thawed only once. Label each aliquot with compound name, concentration, date, and lot number. Minimizing freeze-thaw cycles keeps the migration and angiogenesis readouts in the TB-500 research applications comparable across replicates.

Cold-Chain and Working-Solution Storage

Store reconstituted aliquots frozen for longer holds, and keep short-term working solutions cold and protected from light. Maintain consistent conditions throughout the study period and monitor storage records as part of quality assurance. This practice aligns with the TB-4/TB-500 handling guide for the full-length protein and the BPC/TB500 blend handling guide where the fragment appears.

COA and Lot Verification

Each TB-500 batch ships with a third-party-verified certificate of analysis documenting purity (HPLC / reverse-phase chromatography), mass-spectrometry identity confirmation, and lot, testing date, and method details. Verify the COA against the vial label and retain it with your batch records. Sample COAs can be requested ahead of purchase.

PPE and Institutional Compliance

Handle TB-500 as an investigational material. Follow institutional SOPs, chemical hygiene plans, and approved protocols; wear a lab coat, gloves, and eye protection; and use engineering controls where required. All handling should be performed by qualified personnel in controlled environments. Specifications are on the TB-500 product page.

At intake, match the vial to its recorded synonyms, including Ac-LKKTETQ, and confirm the expected white lyophilized appearance, recording that the material is the actin-binding fragment rather than the full-length protein. This clarity keeps the fragment's data usable as a reference point across studies and against the complete molecule.

Documentation for Cross-Study Comparison

Because TB-500 is a widely used fragment that often serves as a reference point, consistent documentation makes its data comparable across studies. Recording the vial size, diluent volume, final concentration, lot number, and certificate of analysis for each preparation lets independent teams line up their results against a common, well-defined baseline.

When TB-500 is run alongside the full-length protein or within a blend, the record should note which material was used and at what concentration, so the fragment's contribution stays clearly separated. This clarity is what allows the fragment to function reliably as a reference against which broader thymosin beta-4 biology is measured.

Consistent handling is ultimately a reproducibility measure. A TB-500 preparation that is verified against its certificate of analysis, reconstituted gently, aliquoted to limit freeze-thaw, stored under stable cold-chain conditions, and fully documented gives every downstream experiment the same reliable starting material. That consistency is what allows independent laboratories to compare results and build on one another's work with confidence. When a study later proves difficult to reproduce, a complete handling record is often what lets investigators distinguish a genuine biological difference from a preparation artifact, which is why the effort invested in disciplined TB-500 handling repays itself throughout a project.

For research use only. These handling notes describe laboratory practice for TB-500 as a research material supplied by Puritide Research. TB-500 is not approved for human or veterinary use, and nothing here constitutes medical or administration guidance.